(Q39695318)

14 September 2017

title

Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark (English)

1 reference

14 September 2017

0 references

0 references

0 references

4

Kåre Mølbak

0 references

Palle Valentiner-Branth

series ordinal

3

object named as

Palle Valentiner-Branth

1 reference

14 September 2017

Katarina Widgren

1

1 reference

14 September 2017

Jacob Simonsen

series ordinal

2

1 reference

14 September 2017

language of work or name

English

0 references

publication date

18 October 2011

1 reference

14 September 2017

1 reference

14 September 2017

volume

29

1 reference

14 September 2017

issue

52

1 reference

14 September 2017

page(s)

9663-9667

1 reference

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.021

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.021

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.021

Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: a qualitative and quantitative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.021

Predictors of HPV vaccine acceptability: a theory-informed, systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.021

Acceptability of human papillomavirus immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.021

Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.021

Parental acceptance of the human papillomavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.021

Parental attitudes to pre-pubertal HPV vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.021

Attitudes to HPV vaccination among parents of children aged 12-15 years-a population-based survey in Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.021

Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.021

Challenges to vaccinating adolescents: vaccine implementation issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.021

Addressing the vaccine confidence gap.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.021

Postlicensure epidemiology of childhood vaccination: the Danish experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.021

Spatial distribution and registry-based case-control analysis of Campylobacter infections in Denmark, 1991-2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.021

Determinants for HPV vaccine uptake in the Netherlands: A multilevel study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.021

Awareness of human papillomavirus in a cohort of nearly 70,000 women from four Nordic countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.021

10.1016/J.VACCINE.2011.10.021

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference